Since 2007, JonesTrading has offered public companies an alternative vehicle for financing and investment banking through direct access to the investor community. JonesTrading believes corporations have been underserved by the offerings currently available.

SAVA Cassava Sciences, Inc
$200,000,000
At-the-Market
April 2023


BRTX BioRestorative Therapies Inc
$3,700,000
At-the-Market
Sole Sales Agent | April 2023


FBRT Franklin Realty Trust Inc
$200,000,000
At-the-Market
Sales Agent | April 2023


ORC Orchid Island Capital Inc
$250,000,000
At-the-Market
Sales Agent | March 2023


IVR Invesco Mortgage Capital Inc
16,000,000 shares
At-the-Market
Sales Agent | February 2023


DX Dynex Capital Inc
36,117,622 shares
At-the-Market
Sales Agent | February 2023


PIMCO
$500,000,000
PDO - At-the-Market
Sole Sales Agent | February 2023


WULF Terawulf
$25,000,000
Follow-On
Sole Book-Runner | February 2023


PIMCO
$100,000,000
PCN At-the-Market
Sole Sales Agent | January 2023


ISRL Israel Acquisitions Corp.
$125,000,000
ISRL - IPO
Co-Manager | January 2023


MNPR Monopar Therapeutics
$6,505,642
At-the-Market
Sole Sales Agent | January 2023


NMTC NeuroOne Medical Technologies Corp.
$14,500,000
At-the-Market
Sole Sales Agent | December 2022


APTO Aptose Biosciences
$50,000,000
At-the-Market
Sole Sales Agent | December 2022


HIX Western Asset
$143,970,507
At-the-Market
Sole Sales Agent | December 2022


CTO Realty Growth
3,000,000 shares
Follow-On
Co-Manager | November 2022


SAVA Cassava Sciences
$50,000,000
Registered Direct
Capital Markets Advisor | November 2022


TFFP TFF Pharmaceuticals Inc.
$10,675,000
Follow-On
Sole Book-Runner | November 2022


ACET Adicet Bio
$100,000,000
At-the-Market
Sole Sales Agent | November 2022


RAIN Rain Therapeutics Inc.
$50,000,000
Registered Direct
Lead Manager | November 2022


Bullhorn Holdings
Coeptis Therapeutics
$175,000,000
M&A Transaction
Capital Markets Advisor | October 2022


CTO Realty Growth
$150,000,000
At-the-Market
Sales Agent | October 2022


PINE Alpine Income Property Trust
$150,000,000
At-the-Market
Sales Agent | October 2022


EVAX Evaxion Biotech
$14,439,000
At-the-Market
Sole Sales Agent | October 2022


HCWB HCW Biologics
$15,500,000
At-the-Market
Sole Sales Agent | August 2022


UNCY Unicycive Therapeutics
$3,000,000
At-the-Market
Sole Sales Agent | August 2022


PIMCO
$225,000,000
PML - At-the-Market
Sole Sales Agent | August 2022


ACET ADICET BIO
$45,000,000
ATM Direct Transaction


PIMCO
$1,000,000,000
PDI - At-the-Market
Sole Sales Agent | June 2022


DAWN Day One Biopharmaceuticals
$150,000,000
At-the-Market
Sales Agent | June 2022


PIMCO
$200,000,000
PHK - At-the-Market
Sole Sales Agent | June 2022


SIEB Siebert Financial Corp.
$9,600,000
At-the-Market
Sole Sales Agent | May 2022


BOXD Boxed Inc.
$100,000,000
Committed Capital
On-Demand | May 2022


AGLE Aeglea BioTherapeutic
$45,000,000
Registered Direct
Sole Placement Agent | May 2022


CRNX Crinetics Pharmaceuticals
$125,000,000
Follow-On
Co-Manager | April 2022


Clean Earth Acquisitions Corp.
$200,000,000
CLIN - IPO
Co-Manager | February 2022


Cohen & Steers
$305,000,000
RLTY - IPO
Co-Manager | February 2022


EFC Ellington Financial
$100,000,000
Preferred ATM
Sales Agent | January 2022


ACER Acer Therapeutics
$6,850,000
At-the-Market
Sales Agent | December 2021


BOXD Boxed, Inc
$120,000,000
SPAC PIPE & Merger
Placement Agent & Advisor | December 2021


ACET Adicet Bio
$87,500,000
Follow-on
Co-Manager | December 2021


Infint Acquisition Corp
$173,912,000
INFIN - IPO
Joint Book-Runner | November 2021


Credit Suisse
$150,000,000
CIK-At-the-Market
Sole Sales Agent | November 2021


MITT AG Mortgage Investment Trust
$71,750,000
Follow-On
Co-Manager | November 2021


CBAY CymaBay Therapeutics
$75,000,000
Follow-On
Co-Lead Manager | November 2021


ARR Armour Residendial REIT
25,661,843 shares
At-the-Market
Sales Agent | November 2021


IVR Invesco Mortgage Capital, Inc.
$236,250,000
At-the-Market
Sales Agent | November 2021


MEGI CBRE Group Inc.
50,000,000 shares
MEGI-IPO
Co-Manager | October 2021


CNRX Crinetics Pharmaceuticals
$150,000,000
Follow-On
Co-Manager | October 2021


ACR Acres Commercial Realty
2,200,000 shares
Preferred ATM
Sole Sales Agent | October 2021


ECAT BlackRock Inc.
$2,040,000,000
ECAT-IPO
Co-Manager | September 2021


ATAX America First Multifamily Investors, L.P.
$28,975,000
Follow-On
Co-Manager | September 2021


Aberdeen Asset Management
$35,000,000
FCO-At-the-Market
Sole Sales Agent | September 2021


SWSS Springwater Capital
$150,000,000
IPO
Co-Manager | August 2021


NYMT New York Mortgage Trust Inc
$100,000,000
Preferred ATM
Sole Sales Agent | August 2021


SURF Surface Oncology
$80,000,000
At-the-Market
Sole Sales Agent | August 2021


INFI Infinity Pharmaceuticals
$75,000,000
At-the-Market
Sales Agent | July 2021


ATAX America First Multifamily Investors, L.P.
$30,000,000
At-the-Market
Sole Sales Agent | July 2021


BSAQU Black Spade Capital
$150,000,000
IPO
Co-Manager | July 2021


AAIC Arlington
$33,500,000
6% Senior Notes
Co-Manager | July 2021


GEO GEO Group, Inc
$300,000,000
At-the-Market
Sales Agent | June 2021


ORC Orchid Island Capital
$250,000,000
At-the-Market
Sales Agent | June 2021


FEMY Femasys
$34,450,000
IPO
Joint Bookrunner | June 2021


IKT Inhibikase Therapeutics Inc.
$45,000,000
Follow-on
Co-Manager | June 2021


IVR Invesco Mortgage Capital, Inc.
37,500,000 shares
Follow-on
Joint Bookrunner | May 2021


NBXG Neuberger Berman
$1,500,000,000
NBXG - IPO
Co-Manager | May 2021


DMO Western Asset
$43,283,467
DMO-At-the-Market
Sole Sales Agent | May 2021


ALDX Aldeyra
$125,000,000
Follow-on
Co-Manager | April 2021


LFT Lument Finance Trust
$60,000,000
pfd. Follow-on
Co-Manager | April 2021


NUV Nuveen
$575,000,000
NPCT - IPO
Co-Manager | April 2021


VBLT VBL Therapeutics
$25,080,504
Follow-on
Co-Manager | April 2021


BlackRock Inc.
$4,400,000,000
BIGZ - IPO
Co-Manager | March 2021


AVEO Aveo Pharmaceuticals, Inc.
$48,000,000
Follow-On
Co-Manager | March 2021


LIFE aTyr Pharmaceuticals
$25,000,000
At-the-Market
Sole Sales Agent | March 2021


OPA-UN Magnum Opus Acquisition Ltd.
$200,000,000
IPO
Co-Manager | March 2021


CRIS Curis Inc.
$100,000,000
At-the-Market
Sales Agent | March 2021


ACET Adicet Bio
$75,000,000
At-the-Market
Sole Sales Agent | March 2021


OCUP Ocuphire Pharma Inc.
$40,000,000
At-the-Market
Sole Sales Agent | March 2021


ACER Acer Therapeutics
$7,7000,000
At-the-Market
Sales Agent | March 2021


XA Investments
$25,000,000
XFLT - Follow-On
Co-Manager | February 2021


RiverNorth
$440,000,000
RFMZ - IPO
Co-Manager | February 2021


INFI Infinity Pharmaceuticals
$79,800,000
Follow-On
Co-Manager | February 2021


CNSP CNS Pharmaceuticals
$20,000,000
At-the-Market
Sales Agent | February 2021


DX Dynex Capital Inc.
$49,087,500
Follow-On
Co-Manager | January 2021


ALRN Aileron
$30,000,000
At-the-Market
Sales Agent | January 2021


Pimco
$2,000,000,000
PDO - IPO
Co-Manager | January 2021


CMRX Chimerix
$100,000,000
Follow-On
Co-Manager | January 2021


CMO Capstead Mortgage Corp
15,000,000 Common
3,000,000 PFD
At-the-Market
Sales Agent | January 2021


ALRN Aileron Therapeutics Inc.
$35,894,080
Registered Direct
Placement Agent
January 2021


ALRN Aileron Therapeutics Inc.
$11,896,613
At-the-Market
Sole Sales Agent
December 2020


SVOKU Seven Oaks Acquisition Corp
$258,750,000
IPO
Lead Bookrunner
December 2020


ATHE Alterity Therapeutics
$50,000,000
At-the-Market
Sales Agent
December 2020


TCON Tracon Pharmaceuticals Inc.
$50,000,000
At-the-Market
Sole Sales Agent
December 2020


CRIS Curis Inc.
$170,000,000
Follow-On
Joint Bookrunner
December 2020


Pimco
$100,000,000
PCN - At-the-Market
Sole Sales Agent
December 2020


Pimco
$175,000,000
PFN - At-the-Market
Sole Sales Agent
November 2020


Pimco
$120,000,000
PFL - At-the-Market
Sole Sales Agent
November 2020


PGIM
23,750,000 shares
SDHY - IPO
Co-Manager
November 2020


Pimco
$600,000,000
PTY - At-the-Market
Sole Sales Agent
November 2020


Pimco
$600,000,000
PDI - At-the-Market
Sole Sales Agent
November 2020


Cohen & Steers
50,000,000 shares
PTA - IPO
Co-Manager
October 2020


Pimco
$125,000,000
PKO - At-the-Market
Sole Sales Agent
October 2020


Pimco
$1,000,000,000
PCI - At-the-Market
Sole Sales Agent
October 2020


Pimco
4,312,500 shares
PDI - Follow-On
Co-Manager
October 2020


BlackRock, Inc
100,000,000 shares
BCAT - IPO
Co-Manager
September 2020


nuveen
52,000,000 shares
NDMO - IPO
August 2020


ATNM Actinium Pharmaceuticals, Inc.
$200,000,000
At-the-Market
Sole Sales Agent
August 2020


DX Dynex Capital Inc.
$50,000,000
Preferred ATM
Sales Agent
August 2020


ORC Orchid Island Capital Inc.
$150,000,000
At-the-Market
Sales Agent
August 2020


Aberdeen Asset Management
8,850,000 shares
ASGI - IPO
Co-Manager
July 2020


ABIO Arca Biopharma
$54,000,000
At-the-Market
Sole Sales Agent
July 2020


ABIO Arca Biopharma
$14,910,600
At-the-Market
Sole Sales Agent
July 2020


OSTK Overstock
$150,000,000
At-the-Market
Sales Agent
June 2020


First Trust
33,250,000 shares
FTHY - IPO
Co-Manager
June 2020


Angel Oak Capital Advisors
4,050,000 shares
DYFN - IPO
June 2020


CBIO Catalyst Biosciences
$30,000,000
Follow-On
Co-Manager
June 2020


CBIO Catalyst Biosciences
4,615,385 shares
Co-Manager
Follow-On | June 2020


ATNM Actinium Pharmaceuticals, Inc
$24,997,873
Co-Manager
Follow-On | June 2020


CRIS Curis
14,000,000 shares
Registered Direct
June 2020


ABIO Arca Biopharma
$6,061,175
Registered Direct
June 2020


SURF Surface Oncology
$50,000,000
ATM Follow-On
May 2020


SURF Surface Oncology
$28,900,000
ATM Block Trade
May 2020


AGLE Aeglea Biotherapeutics Inc
$119,998,639
Co-Manager
Follow-On | April 2020


ATNM Actinium Pharmaceuticals, Inc
$27,491,750
Co-Manager
Follow-On | April 2020


DMO Western Asset
$50,000,000
ATM Follow-On
April 2020


AGLE Aeglea Biotherapeutics Inc
$60,000,000
ATM Follow-On
April 2020


OSTK Overstock
$80,000,000
ATM Follow-On
April 2020


RFM River North
5,500,000 shares
Initial Public Offering
March 2020


PFL Pimco
$47,700,000
ATM Follow-On
March 2020


PFN Pimco
$76,800,000
ATM Follow-On
March 2020


ACER Acer Therapeutics
$10,000,000
ATM Follow-On
March 2020


CRIS Curis
$30,000,000
ATM Follow-On
March 2020


TCON Tracon Pharma
$1,983,015
ATM Follow-On
February 2020


DLY DoubleLine Funds
46,000,000 shares
Initial Public Offering
February 2020


DX Dynex Capital, Inc.
4,000,000 shares
Preferred New Issue
February 2020


CBIO Catalyst Biosciences
4,615,385 shares
Follow-On | February 2020


IVR Invesco Mortgage Capital Inc.
18,000,000 shares
Co-Manager
Follow-On | February 2020


BMEZ BlackRock
105,000,000 shares
Sole Placement Agent
Initial Public Offering | January 2020


PKO Pimco
$125,000,000
ATM Follow-On
January 2020


ORC Orchid Island Capital
$200,000,000
ATM Follow-On
January 2020


MNPR Monopar Therapeutics
$19,700,000
ATM Follow-On
January 2020


MRTX Mirati Therapeutics
$300,000,000
Co-Manager Follow-On
January 2020


MNPR Monopar Therapeutics
1,111,112 shares
Sole Bookrunner
Initial Public Offering
December 2019


APTO Aptose Biosciences
16,125,000 shares
Co-Manager Follow-On
December 2019


FTSV Forty Seven Inc
4,860,000 shares
Co-Manager Follow-On
December 2019


PCI Pimco
$1,000,000,000
ATM Follow-On
December 2019


HIE Miller Howard Investments
$50,000,000
ATM Follow-On
December 2019


PTY Pimco
$500,000,000
ATM Follow-On
November 2019


PFL Pimco
5,500,000 shares
ATM Follow-On
November 2019


CPZ Calamos Investments
18,250,000 shares
Initial Public Offering
November 2019


PFN Pimco
11,500,000 shares
ATM Follow-On
November 2019


NYMT New York Mortgage Trust
$100,000,000
Preferred ATM
Series B, C, D & E
November 2019


OSTK Overstock
$150,000,000
ATM Follow-On
November 2019


PDI Pimco
$560,000,000
ATM Follow-On
November 2019


PKO Pimco
3,000,000 shares
ATM Follow-On
October 2019


AIO Allianz
30,750,000 shares
Initial Public Offering
October 2019


NMCO Nuveen
Initial Public Offering
September 2019


RMM RiverNorth
18,250,000 shares
Initial Public Offering
July 2019


PTY Pimco
$500,000,000
ATM Follow-On | July 2019


ALRN Aileron
$13,265,506
Sole Placement Agent
ATM Follow-On | July 2019


INFI Infinity Pharmaceuticals
$20,000,000
ATM Follow-On | June 2019


FBIO Fortress Biotech
$50,000,000
ATM Follow-On | June 2019


BSTZ BlackRock
70,000,000 shares
Co-Manager
Initial Public Offering | June 2019


ARQL ArQule
9,250,000 shares
Co-Manager
ATM Follow-On | June 2019


APTS Preferred Apartment Communities
$125,000,000
ATM Follow-On | June 2019


DX Dynex Capital Inc.
25,000,000 shares
ATM Follow-On | May 2019


APTO Aptose Biosciences
10,000,000 shares
Co-Manager
Follow-On | May 2019


FINS Angel Oak Capital Advisors
10,750,000 shares
Initial Public Offering | May 2019


TRMT Tremont Mortgage Trust
5,000,000 shares
Co-Manager
Follow-On | May 2019


BPMX BioPharmx
$8,500,000
ATM Follow-On | May 2019


SURF Surface Oncology
$30,000,000
ATM Follow-On | May 2019


Sharebite
$3,000,000
Sole Placement Agent
Series A Financing | May 2019


ATNM Actinium Pharmaceuticals
42,860,000 shares
Co-Manager
Follow-On | April 2019


NYMT New York Mortgage Trust
$50,000,000
Preferred ATM
Series B, C & D | March 2019


TEAF Tortoise
13,000,000 shares
Initial Public Offering
March 2019


AI Arlington
1,647,370 shares
Preferred ATM
Series B | March 2019


IVR Invesco Mortgage Capital
7,000,000 shares
Preferred ATM
Series A, B & C | March 2019


OSTK Overstock
$52,801,423
ATM Follow-On | March 2019


AI Arlington
1,200,000 shares
Co-Manager
Preferred New Issue | March 2019


AI Arlington
6,000,000 shares
Co-Manager
Follow-On | February 2019


NRGX Pimco
40,000,000 shares
Initial Public Offering
January 2019


ABIO ARCA biopharma
$2,499,876
ATM Follow-On | January 2019


ATNM Actinium Pharmaceuticals
75,000,000 shares
ATM Follow-On | December 2018


JHAA Nuveen
Initial Public Offering
December 2018


CLSN Celsion Corporation
$16,000,000
ATM Follow-On | December 2018


PTY Pimco
14,500,000 shares
ATM Follow-On | November 2018


agbiotic
$5,000,000
Sole Placement Agent
Series A Financing | October 2018


VSTM Verastem Oncology
$150,000,000
Co-Manager
Convertible Sr. Notes | October 2018


REIT Select Income
24,918,421 shares
Co-Manager
Secondary Sale | October 2018


ALDX Aldeyra Therapeutics
5,250,000 shares
Co-Manager
Follow-On | September 2018


PFL Pimco
5,500,000 shares
ATM Follow-On | September 2018


PFN Pimco
11,500,000 shares
ATM Follow-On | September 2018


TCON Tracon Pharmaceuticals
$11,550,332
ATM Follow-On | September 2018


DX Dynex Capital
$50,000,000
Preferred ATM | September 2018


RIV RiverNorth
3,300,000 shares
ATM Follow-On | August 2018


SDI Standard Diversified
$6,500,000
ATM Follow-On | August 2018


OSTK Overstock
$150,000,000
ATM Follow-On | August 2018


ATAX America First Multifamily Investors, L.P.
$75,000,000
ATM Follow-On | August 2018


ARQL ArQule
12,650,000 shares
Co-Manager
ATM Follow-On | July 2018


PKO Pimco
3,000,000 shares
ATM Follow-On | July 2018


CGO Calamos
2,685,638 shares
ATM Follow-On | June 2018


PTY Pimco
14,500,000 shares
ATM Follow-On | June 2018


TTOO T2 Biosystems
7,015,000 shares
Co-Manager
Follow-On | May 2018


AGLE Aeglea Biotherapeutics
4,500,000 shares
Lead Manager
Follow-On | April 2018


ONVO Organovo
$50,000,000
ATM Follow-On | March 2018


FPL First Trust
5,000,000 shares
ATM Follow-On | March 2018


FEI First Trust
4,600,000 shares
ATM Follow-On | March 2018


FEN First Trust
2,800,000 shares
ATM Follow-On | March 2018


HIE Miller Howard Investments
$50,000,000
ATM Follow-On | March 2018


CHY Calamos
6,232,167 shares
ATM Follow-On | March 2018


DHY Credit Suisse
16,690,564 shares
ATM Follow-On | February 2018


CBIO Catalyst Biosciences
$115,500,000
Follow-On Offering
Sole Bookrunning Manager | February 2018


PTIE Pain Therapeutics, Inc
$16,900,000
ATM Follow-On | February 2018


ILPT Industrial Logistics Property Trust
20,000,000 shares
Underwriter
IPO | January 2018


CBIO Catalyst Biosciences
$10,500,000
Follow-On Offering
Joint Book-Runner | December 2017


PDI Pimco
9,500,000 shares
ATM Follow-On | December 2017


ATAX America First Multifamily Investors, L.P.
$75,000,000
ATM Follow-On | December 2017


PRAN Prana Biotechnology
$10,019,412
ATM Follow-On | November 2017


HIE Miller Howard Investments
$50,000,000
ATM Follow-On | October 2017


ABEO Abeona Therapeutics
5,000,000 shares
Follow-On Offering
Co-Manager | October 2017


CHY Calamos
6,232,167 shares
ATM Follow-On | October 2017


CHI Calamos
7,500,000 shares
ATM Follow-On | October 2017


TTOO T2 Biosystems
4,375,000 shares
Follow-On
Co-Manager | September 2017


IRT Independence Realty Trust
12,500,000 shares
Follow-On
Co-Manager | September 2017


ABIO ARCA biopharma
$3,568,486
ATM Follow-On | August 2017


OMER Omeros Corp
3,000,000 shares
Co-Manager
Follow-On | August 2017


ATNM Actinum Pharmaceuticals
$16,125,000
Follow-On
Co-Manager | July 2017


DHY Credit Suisse
20,000,000 shares
ATM Follow-On | July 2017


APTS Preferred Apartment Communities
$150,000,000
ATM Follow-On | July 2017


FPL First Trust
5,000,000
ATM Follow-On | July 2017


ATNM Actinum Pharmaceuticals
$75,000,000
ATM Follow-On | July 2017


GOV Government Properties Income Trust
25,000,000 shares
Follow-On Offering
Co-Manager | June 2017


FEN First Trust
2,800,000 shares
ATM Follow-On | June 2017


FEI First Trust
4,600,000 shares
ATM Follow-On | June 2017


AGLE Aeglea Biotherapeutics
3,000,000 shares
Follow-On Offering
Sole Book-Runner | June 2017


AI Arlington Asset Investment Corp
1,865,000 shares
Preferred ATM, Series B | May 2017


APTS Preferred Apartment Communities
$48,000,000
Follow-On Offering
Co-Lead Manager | May 2017


AI Arlington Asset Investment Corp
135,000 shares
Series B Pref.
New Issue | May 2017


AGLE Aeglea Biotherapeutics
$20,000,000
ATM Follow-On | May 2017


HT Hersha Hospitality Trust
8,000,000 shares
Class A, Series E + D Pfd
ATM Follow-On | April 2017


PDI Pimco
9,500,000 shares
ATM Follow-On | March 2017


PTY Pimco
14,500,000 shares
ATM Follow-On | March 2017


CBIO Catalyst Biosciences
$115,000,000
Follow-On Offering
Sole Bookrunning Manager | February 2018


AI Arlington Asset Investment Corp
6,000,000 shares
ATM Follow-On | February 2017


Medley Capital Corporation
$34,500,000
Baby Bond
Joint Book-Runner | February 2017


CBAY CymaBay Therapeutics
5,181,348 shares
Follow-On Offering
Sole Book-Runner | February 2017


Medley Capital Corporation
$34,500,000
Baby Bond
Joint Book-Runner | February 2017


ABIO ARCA biopharma
$7,300,000
ATM Follow-On | January 2017
